Trials / Withdrawn
WithdrawnNCT04541719
Patient Controlled Remifentanil Analgesia for Normal Labour
Patient Controlled Remifentanil Analgesia vs. Epidural Analgesia for Normal Labour. A Prospective Randomised Study
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Patient controlled remifentanil analgesia might offer comparative overall patient satisfaction and improved quality of analgesia after normal labour with continuous epidural analgesia.
Detailed description
We are aiming to study the effects of patient controlled remifentanil analgesia and epidural analgesia for normal labour in full term parturients on: * Peripartum analgesia * Overall patient's satisfaction * Maternal adverse effects * Neonatal outcomes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Patient-controlled remifentanil analgesia | Patient controlled remifentanil analgesia with a regimen to provide a bolus of 40 μg remifentanil with a lockout interval of 2 min |
| DRUG | Epidural analgesia | Patients will receive continuous epidural analgesia using bupivacaine 0.125% in conjunction with fentanyl 2 ug/ml at a rate of 8-15 ml/hr |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2018-05-01
- Completion
- 2018-07-01
- First posted
- 2020-09-09
- Last updated
- 2020-09-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04541719. Inclusion in this directory is not an endorsement.